益生菌补充剂对绝经后妇女骨密度和骨转换标志物的影响:一项系统综述。

IF 2.6 Q3 NUTRITION & DIETETICS
Harini J N , Gayathri G , Shriraam Mahadevan , Ilangovan R
{"title":"益生菌补充剂对绝经后妇女骨密度和骨转换标志物的影响:一项系统综述。","authors":"Harini J N ,&nbsp;Gayathri G ,&nbsp;Shriraam Mahadevan ,&nbsp;Ilangovan R","doi":"10.1016/j.clnesp.2025.07.1117","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><div>Probiotics have garnered attention for their potential to influence bone health through interactions with the gut microbiota. This systematic review evaluates the effects of probiotic interventions on bone mineral density (BMD) and bone turnover markers in postmenopausal women who are at the risk of osteopenia or osteoporosis.</div></div><div><h3>Methods</h3><div>A thorough search across databases from January 2010 to April 2024 identified relevant randomized controlled trials (RCTs). Eligible studies explored the relationship of consumption of probiotics with bone health parameters, with data screening, extraction, and quality assessment performed based on predefined criteria.</div></div><div><h3>Results</h3><div>Eight RCTs were included, investigating various probiotic interventions. The analysis showed no significant impact of probiotics on hip BMD [standardized mean difference (SMD) = 0.17, 95 % confidence intervals (CIs): −0.16 to 0.50] or spine BMD (SMD = 0.04, 95 % CIs: −0.14 to 0.22). Similarly, no significant effects were observed in bone formation markers (SMD = −0.12, 95 % CI: −0.34 to 0.11). However, bone resorption markers showed marginal but significant effects (SMD = −0.19, 95 % CI: −0.40 to 0.01). Heterogeneity ranged from low to moderate, and publication bias was not significant.</div></div><div><h3>Conclusion</h3><div>Our results did not show a significant relationship of probiotic consumption with the BMD and bone formation in human studies. However, the observed changes in bone resorption markers indicate a potentially beneficial effects of probiotics. Although probiotics may not serve as a primary treatment for osteoporosis, they could be incorporated into a comprehensive bone health strategy.</div></div>","PeriodicalId":10352,"journal":{"name":"Clinical nutrition ESPEN","volume":"69 ","pages":"Pages 503-515"},"PeriodicalIF":2.6000,"publicationDate":"2025-07-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Effects of probiotic supplements on bone mineral density and bone turnover markers in postmenopausal women: A systematic review\",\"authors\":\"Harini J N ,&nbsp;Gayathri G ,&nbsp;Shriraam Mahadevan ,&nbsp;Ilangovan R\",\"doi\":\"10.1016/j.clnesp.2025.07.1117\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><h3>Background</h3><div>Probiotics have garnered attention for their potential to influence bone health through interactions with the gut microbiota. This systematic review evaluates the effects of probiotic interventions on bone mineral density (BMD) and bone turnover markers in postmenopausal women who are at the risk of osteopenia or osteoporosis.</div></div><div><h3>Methods</h3><div>A thorough search across databases from January 2010 to April 2024 identified relevant randomized controlled trials (RCTs). Eligible studies explored the relationship of consumption of probiotics with bone health parameters, with data screening, extraction, and quality assessment performed based on predefined criteria.</div></div><div><h3>Results</h3><div>Eight RCTs were included, investigating various probiotic interventions. The analysis showed no significant impact of probiotics on hip BMD [standardized mean difference (SMD) = 0.17, 95 % confidence intervals (CIs): −0.16 to 0.50] or spine BMD (SMD = 0.04, 95 % CIs: −0.14 to 0.22). Similarly, no significant effects were observed in bone formation markers (SMD = −0.12, 95 % CI: −0.34 to 0.11). However, bone resorption markers showed marginal but significant effects (SMD = −0.19, 95 % CI: −0.40 to 0.01). Heterogeneity ranged from low to moderate, and publication bias was not significant.</div></div><div><h3>Conclusion</h3><div>Our results did not show a significant relationship of probiotic consumption with the BMD and bone formation in human studies. However, the observed changes in bone resorption markers indicate a potentially beneficial effects of probiotics. Although probiotics may not serve as a primary treatment for osteoporosis, they could be incorporated into a comprehensive bone health strategy.</div></div>\",\"PeriodicalId\":10352,\"journal\":{\"name\":\"Clinical nutrition ESPEN\",\"volume\":\"69 \",\"pages\":\"Pages 503-515\"},\"PeriodicalIF\":2.6000,\"publicationDate\":\"2025-07-25\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Clinical nutrition ESPEN\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S2405457725028682\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"NUTRITION & DIETETICS\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical nutrition ESPEN","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2405457725028682","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"NUTRITION & DIETETICS","Score":null,"Total":0}
引用次数: 0

摘要

背景:益生菌通过与肠道菌群相互作用影响骨骼健康的潜力引起了人们的关注。本系统综述评估了益生菌干预对有骨质减少或骨质疏松风险的绝经后妇女骨密度(BMD)和骨转换标志物(BTM)的影响。方法:全面检索2010年1月至2024年4月的数据库,确定相关的随机对照试验(rct)。符合条件的研究探讨了益生菌的摄入与骨骼健康参数的关系,并根据预定义的标准进行了数据筛选、提取和质量评估。结果:纳入8项随机对照试验,研究各种益生菌干预措施。分析显示,益生菌对髋部骨密度(BMD)(标准化平均差[SMD] = 0.17, 95%可信区间[ci]: -0.16至0.50)或脊柱骨密度(SMD = 0.04, 95% ci: -0.14至0.22)无显著影响。同样,在骨形成标记物中未观察到显著影响(SMD= -0.12, 95% CI: -0.34至0.11)。然而,骨吸收标记物的影响微乎其微(SMD = - 0.19, 95% CI: -0.40 ~ 0.01)。异质性从低到中等不等,发表偏倚不显著。结论:在人体研究中,我们的研究结果没有显示益生菌摄入与骨密度和骨形成的显著关系。然而,观察到的骨转换标志物的变化表明益生菌具有潜在的有益作用。虽然益生菌可能不能作为骨质疏松症的主要治疗方法,但它们可以被纳入一个全面的骨骼健康策略。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Effects of probiotic supplements on bone mineral density and bone turnover markers in postmenopausal women: A systematic review

Background

Probiotics have garnered attention for their potential to influence bone health through interactions with the gut microbiota. This systematic review evaluates the effects of probiotic interventions on bone mineral density (BMD) and bone turnover markers in postmenopausal women who are at the risk of osteopenia or osteoporosis.

Methods

A thorough search across databases from January 2010 to April 2024 identified relevant randomized controlled trials (RCTs). Eligible studies explored the relationship of consumption of probiotics with bone health parameters, with data screening, extraction, and quality assessment performed based on predefined criteria.

Results

Eight RCTs were included, investigating various probiotic interventions. The analysis showed no significant impact of probiotics on hip BMD [standardized mean difference (SMD) = 0.17, 95 % confidence intervals (CIs): −0.16 to 0.50] or spine BMD (SMD = 0.04, 95 % CIs: −0.14 to 0.22). Similarly, no significant effects were observed in bone formation markers (SMD = −0.12, 95 % CI: −0.34 to 0.11). However, bone resorption markers showed marginal but significant effects (SMD = −0.19, 95 % CI: −0.40 to 0.01). Heterogeneity ranged from low to moderate, and publication bias was not significant.

Conclusion

Our results did not show a significant relationship of probiotic consumption with the BMD and bone formation in human studies. However, the observed changes in bone resorption markers indicate a potentially beneficial effects of probiotics. Although probiotics may not serve as a primary treatment for osteoporosis, they could be incorporated into a comprehensive bone health strategy.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Clinical nutrition ESPEN
Clinical nutrition ESPEN NUTRITION & DIETETICS-
CiteScore
4.90
自引率
3.30%
发文量
512
期刊介绍: Clinical Nutrition ESPEN is an electronic-only journal and is an official publication of the European Society for Clinical Nutrition and Metabolism (ESPEN). Nutrition and nutritional care have gained wide clinical and scientific interest during the past decades. The increasing knowledge of metabolic disturbances and nutritional assessment in chronic and acute diseases has stimulated rapid advances in design, development and clinical application of nutritional support. The aims of ESPEN are to encourage the rapid diffusion of knowledge and its application in the field of clinical nutrition and metabolism. Published bimonthly, Clinical Nutrition ESPEN focuses on publishing articles on the relationship between nutrition and disease in the setting of basic science and clinical practice. Clinical Nutrition ESPEN is available to all members of ESPEN and to all subscribers of Clinical Nutrition.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信